LTR Research Development from 2010 to 2026
| LTP Stock | 0.49 0.02 3.92% |
Research Development | First Reported 2010-12-31 | Previous Quarter 4 M | Current Value 4.2 M | Quarterly Volatility 1.5 M |
Check LTR Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LTR Pharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 98.8 K or Interest Expense of 361, as well as many indicators such as . LTR financial statements analysis is a perfect complement when working with LTR Pharma Valuation or Volatility modules.
LTR | Research Development |
The evolution of Research Development for LTR Pharma provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how LTR Pharma compares to historical norms and industry peers.
Latest LTR Pharma's Research Development Growth Pattern
Below is the plot of the Research Development of LTR Pharma over the last few years. It is LTR Pharma's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LTR Pharma's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
LTR Research Development Regression Statistics
| Arithmetic Mean | 1,192,583 | |
| Geometric Mean | 642,853 | |
| Coefficient Of Variation | 127.00 | |
| Mean Deviation | 1,236,010 | |
| Median | 348,305 | |
| Standard Deviation | 1,514,545 | |
| Sample Variance | 2.3T | |
| Range | 3.9M | |
| R-Value | 0.76 | |
| Mean Square Error | 1T | |
| R-Squared | 0.58 | |
| Significance | 0.0004 | |
| Slope | 229,100 | |
| Total Sum of Squares | 36.7T |
LTR Research Development History
About LTR Pharma Financial Statements
LTR Pharma shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although LTR Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in LTR Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on LTR Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 4 M | 4.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LTR Stock Analysis
When running LTR Pharma's price analysis, check to measure LTR Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LTR Pharma is operating at the current time. Most of LTR Pharma's value examination focuses on studying past and present price action to predict the probability of LTR Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LTR Pharma's price. Additionally, you may evaluate how the addition of LTR Pharma to your portfolios can decrease your overall portfolio volatility.